Interventions in Persistent Hot-Spots in Tanzania

How do villages which do not show substantial decreases in the prevalence of schistosomiasis despite repeated, high coverage mass drug administration (persistent hot-spot villages) differ from villages which show substantial decrease in prevalence across various factors (declining prevalence villages)?


WHO Region: AFRO


Email primary contact

Please log in or register